Keywords: bayer, signs, deal, prostrakan, tostrex, germany-based, schering

Bayer signs deal for ProStrakan's Tostrex

Article | 15 December 2008

Germany-based Bayer Schering Pharma has signed an agreement to develop and commercialize Scottish drugmaker ProStrakan's Tostrex in Canada, Latin America, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in